
Gilead Sciences GILD
$ 144.65
-0.39%
Annual report 2025
added 02-24-2026
Gilead Sciences P/E Ratio 2011-2026 | GILD
Annual P/E Ratio Gilead Sciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.6 | 298 | 16.2 | 22.7 | 14.7 | 576 | 15.1 | 16.6 | 24.7 | 7.09 | 6.71 | 13.2 | 40.5 | 23.3 | 13.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 576 | 6.71 | 74 |
P/E Ratio of other stocks in the Biotechnology industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
AbCellera Biologics
ABCL
|
-6.57 | $ 3.54 | -0.56 % | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
-4.18 | $ 3.2 | 2.24 % | $ 229 M | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
-0.608 | - | 10.36 % | $ 9.8 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
ADC Therapeutics SA
ADCT
|
-5.3 | $ 4.17 | -1.18 % | $ 105 M | ||
|
Aptorum Group Limited
APM
|
-0.958 | $ 0.8 | 1.81 % | $ 4.36 M | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-3.3 | $ 6.55 | -1.21 % | $ 179 M | ||
|
argenx SE
ARGX
|
-33.7 | $ 710.47 | 1.02 % | $ 25 B | ||
|
Adverum Biotechnologies
ADVM
|
-0.583 | - | - | $ 86.2 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 3.41 | -5.54 % | $ 8.2 B | ||
|
Ascendis Pharma A/S
ASND
|
-19.2 | $ 229.89 | -0.49 % | $ 5 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
BioCardia
BCDA
|
-0.769 | $ 1.28 | 0.55 % | $ 27.1 M | ||
|
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | ||
|
Atea Pharmaceuticals
AVIR
|
-2.69 | $ 6.12 | 1.16 % | $ 499 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | ||
|
Athersys
ATHX
|
-4.62 | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
-2.17 | - | 3.16 % | $ 1.9 M | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
AlloVir
ALVR
|
-0.833 | - | 4.14 % | $ 49.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-400 | $ 3.51 | -2.23 % | $ 7.64 B | ||
|
Catalyst Biosciences
CBIO
|
101 | $ 11.32 | -2.25 % | $ 1.01 B | ||
|
Anika Therapeutics
ANIK
|
-4.51 | $ 14.64 | 1.92 % | $ 215 M | ||
|
Aptinyx
APTX
|
-0.146 | - | -39.0 % | $ 4.57 M | ||
|
Aptose Biosciences
APTO
|
-0.0913 | - | -45.71 % | $ 1.2 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-1.84 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
CNS Pharmaceuticals
CNSP
|
-0.035 | $ 2.28 | -6.94 % | $ 872 K | ||
|
Aytu BioScience
AYTU
|
-1.16 | $ 2.64 | - | $ 16.6 M | ||
|
Curis
CRIS
|
-0.305 | $ 0.88 | 2.58 % | $ 5.55 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0465 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
-1.92 | $ 1.51 | - | $ 385 M | ||
|
BioNTech SE
BNTX
|
6.11 | $ 92.24 | 1.88 % | $ 27.2 B | ||
|
Athira Pharma
ATHA
|
-0.167 | - | - | $ 269 M | ||
|
CureVac N.V.
CVAC
|
-8.58 | - | - | $ 867 M |